Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225
about
Emerging treatment options for nasopharyngeal carcinomaPatterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidenceLong-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.Treatment of nasopharyngeal carcinoma using simultaneous modulated accelerated radiation therapy via helical tomotherapy: a phase II study.Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter studySafety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.Development of a gene transfer-based treatment for radiation-induced salivary hypofunctionClinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.Use dose bricks concept to implement nasopharyngeal carcinoma treatment planningCurrent management strategy of nasopharyngeal carcinoma.PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy.Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes.Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapyHypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.Cardiac avoidance in breast radiotherapy: many choices for a worthwhile objective.DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomasAdaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma.High weight loss during radiation treatment changes the prognosis in under-/normal weight nasopharyngeal carcinoma patients for the worse: a retrospective analysis of 2433 casesRules of parotid gland dose variations and shift during intensity modulated radiation therapy for nasopharyngeal carcinoma.Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients.Actual anatomical and dosimetric changes of parotid glands in nasopharyngeal carcinoma patients during intensity modulated radiation therapy.Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinomaPrognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosisAntifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapyTechnical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.The impact of reduced-volume, intensity-modulated radiation therapy on disease control in nasopharyngeal carcinoma.[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated RadiotherapyInvestigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysisThe impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.The pattern of relapse and survival of elective irradiation of the upper neck for stage N0 nasopharyngeal carcinoma.Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
P2860
Q26995560-8CBB0264-53D0-4D09-9223-941CA99CBF99Q27007474-01B3608F-F788-4572-8F3D-4A0B5EF39523Q33425830-34C82C1A-B047-462D-8A82-0A5030C842C9Q33429679-C5DB23C0-0F62-4759-B65C-16D248E299FBQ33432643-0416F9D0-C936-44E3-A4EE-30B6D2BCAE6CQ33436774-D44D7017-A062-4A59-80B5-70BB846217C1Q33439337-B9ADA900-10E5-4E55-8C45-1942F4733570Q33442582-81BE9428-89BF-4E0D-B5D1-E7C20E3C772BQ33637630-BBF9A42D-A952-45F8-89A8-01C63A3544F1Q33689119-1BD6199A-A205-491A-90CF-8328952BE24BQ33747577-46D1F523-F489-40BE-A140-86C616D6B677Q33764579-67188876-0F59-4064-82C2-3743AABDC27CQ33771373-B23368E4-0362-499F-8062-64BF46AD2B1EQ33779881-779BC430-659D-4904-B9F0-EF266BCEBA9FQ33907143-7EE9D719-F462-4FE2-A835-2B8E1BA68D28Q33961339-3FB6CEBD-64A0-4969-8D00-45A4435D31EAQ33994022-75FDFB6B-669E-4D04-988E-DC0311CF168AQ34069855-C430F84A-C730-4225-ADF5-122EAC095AA5Q34185676-7A486EB5-E833-4A56-BD9A-4939A588902BQ34297359-2A3D4902-47D6-4850-B552-1630D5EB1444Q34582022-6BFDE016-D261-4DDA-B4F1-5A37079DE6FCQ34743124-7A79A3F1-C694-4C71-867A-9E33C28AEF99Q34788288-A46ECD56-5547-4AE7-B66E-E27D39318A80Q34837838-BF700ACE-BB5C-40D5-AA8A-51C4A0F433ACQ34984605-D091BB51-F03F-4F72-9A60-86C8102B0556Q35042007-CE525B17-7D76-40B8-8B57-8103B0EC24DEQ35156044-2178E483-506B-47BF-A274-73C076241BBEQ35184996-9B8F84E0-72F0-4DC8-B70C-CFB73D6ACA75Q35231227-859EEB2B-73DE-488E-85BB-46B4F59D8FEFQ35238239-0D3D3CBF-2318-461C-9FFC-5BFB020875D6Q35534813-BDC29D1A-C566-448D-9186-19BA2135A557Q35547568-8CB489B1-E2F1-4843-9574-F4C7F9612B40Q35586691-1B5C95EC-930B-496B-82D5-A741A4E6F57EQ35675444-3050DC17-D90B-484F-8156-9595CD2F907DQ35717112-16862D5F-5F48-4A12-9280-442BB59940BCQ35739003-5B27792A-A02B-4118-B79F-A122EDB9F112Q35809636-90E36287-DFB7-426E-8D73-3670AFAF3AFEQ35870838-4578A086-9EC7-4262-B4C0-7A92E8BB945EQ35963310-F48B1392-96F8-4C32-B30F-A9C10D48B495Q35973996-91DBE4ED-02A2-4187-957C-FD4F883B489D
P2860
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intensity-modulated radiation ...... logy group phase II trial 0225
@en
Intensity-modulated radiation ...... ogy group phase II trial 0225.
@nl
type
label
Intensity-modulated radiation ...... logy group phase II trial 0225
@en
Intensity-modulated radiation ...... ogy group phase II trial 0225.
@nl
prefLabel
Intensity-modulated radiation ...... logy group phase II trial 0225
@en
Intensity-modulated radiation ...... ogy group phase II trial 0225.
@nl
P2093
P2860
P921
P356
P1476
Intensity-modulated radiation ...... logy group phase II trial 0225
@en
P2093
Adam S Garden
Bonnie Glisson
Christopher Jones
Jeanne Quivey
Jonathan Harris
K Kian Ang
Wade Thorstad
Walter Bosch
P2860
P304
P356
10.1200/JCO.2008.19.9109
P407
P577
2009-06-29T00:00:00Z